Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular DegenerationGui‐Shuang Ying, Daniel Martín, Dante J. Pieramici et al.|Ophthalmology|2012Cited by 310